1. Search Result
Search Result
Results for "

let-7

" in MedChemExpress (MCE) Product Catalog:

91

Inhibitors & Agonists

84

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-112659

    MicroRNA Neurological Disease Cancer
    Lin28-let-7 antagonist 1 (compound 1632) is a potent antagonist of Lin28/pre-let-7 interaction. Lin28-let-7 antagonist 1 inhibits Lin28A binding to pre-let-7a-2, with an IC50 of 8 μM. Lin28-let-7 antagonist 1 inhibits proliferation in human cancer cells .
    Lin28-let-7 antagonist 1
  • HY-100692
    Lin28-let-7a antagonist 1
    2 Publications Verification

    MicroRNA Cancer
    Lin28-let-7a antagonist 1 shows a clear antagonistic effect against the Lin28-let-7a interaction with an IC50 of 4.03 μM for Lin28A-let-7a-1 interaction.
    Lin28-let-7a antagonist 1
  • HY-123905

    MicroRNA Parasite Infection Cancer
    LIN28 inhibitor LI71 is a LIN28 inhibitor that effectively inhibits LIN28:let-7 binding (IC50: 7 μM). LIN28 inhibitor LI71 can abolish LIN28-mediated oligouridylation of let-7 precursor (IC50: 27 μM). LIN28 inhibitor LI71 has potential application value in LIN28-driven cancer research. LIN28 inhibitor LI71 inhibits the interaction of cold shock protein of Plasmodium falciparum (PfCoSP) with DNA and α/β tubulin and has an inhibitory effect on Plasmodium falciparum .
    LIN28 inhibitor LI71
  • HY-R00003

    MicroRNA Cancer
    hsa-let-7a-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7a-5p mimic
    hsa-let-7a-5p mimic
  • HY-177733

    Molecular Glues MicroRNA Cancer
    Lin28 degrader MG-Lin3 is a molecular glucose degrading agent that targets the Lin28 protein. Lin28 degrader MG-Lin3 significantly reduces the Renilla luciferase signal at 100 µM. Lin28 degrader MG-Lin3 inhibits the maturation of tumor microRNA let-7. Lin28 degrader MG-Lin3 can be used for cancer research .
    MG-Lin3
  • HY-177731

    Molecular Glues MicroRNA Cancer
    Lin28 degrader MG-Lin1 is a molecular glucose degrading agent that targets the Lin28 protein. Lin28 degrader MG-Lin1 can significantly reduce the mRNA levels of let-7 targeting oncogenes. Lin28 degrader MG-Lin1 can significantly inhibit the migration ability of cancer cells. Lin28 degrader MG-Lin1 has no obvious cytotoxicity. Lin28 degrader MG-Lin1 can be used for cancer research .
    MG-Lin1
  • HY-155237

    MicroRNA Cancer
    LIN28-IN-1 (compound 5) is an inhibitor of the RNA-binding and regulatory protein LIN28 and binds to the LIN28 cold shock domain (CSD). LIN28-IN-1 effectively inhibits the interaction between LIN28 and let-7 miRNA (IC50: 5.4 μM), blocking the negative impact of LIN28 on epigenetic gene regulation. LIN28-IN-1 significantly inhibits the proliferation of JAR cancer cells expressing LIN28 (IC50: 6.4 μM) .
    LIN28-IN-1
  • HY-R02560

    MicroRNA Cancer
    mmu-let-7j mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-let-7j mimic
    mmu-let-7j mimic
  • HY-R02561

    MicroRNA Cancer
    mmu-let-7k mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-let-7k mimic
    mmu-let-7k mimic
  • HY-R00002

    MicroRNA Cancer
    hsa-let-7a-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7a-3p mimic
    hsa-let-7a-3p mimic
  • HY-R04633

    MicroRNA Others
    hsa-let-7d-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7d-5p mimic
    hsa-let-7d-5p mimic
  • HY-R00008

    MicroRNA Cancer
    hsa-let-7d-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7d-3p mimic
    hsa-let-7d-3p mimic
  • HY-R00007

    MicroRNA Cancer
    hsa-let-7c-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7c-5p mimic
    hsa-let-7c-5p mimic
  • HY-R00014

    MicroRNA Cancer
    hsa-let-7i-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7i-5p mimic
    hsa-let-7i-5p mimic
  • HY-R04616

    MicroRNA Others
    mmu-let-7i-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-let-7i-5p mimic
    mmu-let-7i-5p mimic
  • HY-R00013

    MicroRNA Cancer
    hsa-let-7i-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7i-3p mimic
    hsa-let-7i-3p mimic
  • HY-R00004

    MicroRNA Cancer
    hsa-let-7b-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7b-3p mimic
    hsa-let-7b-3p mimic
  • HY-R00005

    MicroRNA Cancer
    hsa-let-7b-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7b-5p mimic
    hsa-let-7b-5p mimic
  • HY-R00006

    MicroRNA Cancer
    hsa-let-7c-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7c-3p mimic
    hsa-let-7c-3p mimic
  • HY-R04617

    MicroRNA Others
    mmu-let-7f-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-let-7f-5p mimic
    mmu-let-7f-5p mimic
  • HY-R04623

    MicroRNA Others
    rno-let-7i-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    rno-let-7i-5p mimic
    rno-let-7i-5p mimic
  • HY-R00009

    MicroRNA Cancer
    hsa-let-7e-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7e-3p mimic
    hsa-let-7e-3p mimic
  • HY-R00012

    MicroRNA Cancer
    hsa-let-7g-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7g-5p mimic
    hsa-let-7g-5p mimic
  • HY-RI02561

    MicroRNA Cancer
    mmu-let-7k inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-let-7k inhibitor
    mmu-let-7k inhibitor
  • HY-RI02560

    MicroRNA Cancer
    mmu-let-7j inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-let-7j inhibitor
    mmu-let-7j inhibitor
  • HY-R02557

    MicroRNA Cancer
    mmu-let-7a-1-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-let-7a-1-3p mimic
    mmu-let-7a-1-3p mimic
  • HY-R02558

    MicroRNA Cancer
    mmu-let-7a-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-let-7a-2-3p mimic
    mmu-let-7a-2-3p mimic
  • HY-R00001

    MicroRNA Cancer
    hsa-let-7a-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7a-2-3p mimic
    hsa-let-7a-2-3p mimic
  • HY-R02559

    MicroRNA Cancer
    mmu-let-7f-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    mmu-let-7f-2-3p mimic
    mmu-let-7f-2-3p mimic
  • HY-R00010

    MicroRNA Cancer
    hsa-let-7f-1-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7f-1-3p mimic
    hsa-let-7f-1-3p mimic
  • HY-R04205

    MicroRNA Cancer
    rno-let-7f-1-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    rno-let-7f-1-3p mimic
    rno-let-7f-1-3p mimic
  • HY-R00011

    MicroRNA Cancer
    hsa-let-7f-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-let-7f-2-3p mimic
    hsa-let-7f-2-3p mimic
  • HY-123905A

    Drug Isomer MicroRNA Parasite Infection Cancer
    LIN28 inhibitor LI71 enantiomer is the less active enantiomer of LIN28 inhibitor LI71 (HY-123905). LIN28 inhibitor LI71 is a LIN28 inhibitor that effectively inhibits LIN28:let-7 binding (IC50: 7 μM). LIN28 inhibitor LI71 can abolish LIN28-mediated oligouridylation of let-7 precursor (IC50: 27 μM). LIN28 inhibitor LI71 has potential application value in LIN28-driven cancer research. LIN28 inhibitor LI71 inhibits the interaction of cold shock protein of Plasmodium falciparum (PfCoSP) with DNA and α/β tubulin and has an inhibitory effect on Plasmodium falciparum .
    LIN28 inhibitor LI71 enantiomer
  • HY-R02561A

    MicroRNA Cancer
    mmu-let-7k agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-let-7k agomir
    mmu-let-7k agomir
  • HY-R02560A

    MicroRNA Cancer
    mmu-let-7j agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    mmu-let-7j agomir
    mmu-let-7j agomir
  • HY-RI00002

    MicroRNA Cancer
    hsa-let-7a-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7a-3p inhibitor
    hsa-let-7a-3p inhibitor
  • HY-RI00003

    MicroRNA Cancer
    hsa-let-7a-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7a-5p inhibitor
    hsa-let-7a-5p inhibitor
  • HY-RI00014

    MicroRNA Cancer
    hsa-let-7i-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7i-5p inhibitor
    hsa-let-7i-5p inhibitor
  • HY-RI00012

    MicroRNA Cancer
    hsa-let-7g-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7g-5p inhibitor
    hsa-let-7g-5p inhibitor
  • HY-RI00005

    MicroRNA Cancer
    hsa-let-7b-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7b-5p inhibitor
    hsa-let-7b-5p inhibitor
  • HY-RI00004

    MicroRNA Cancer
    hsa-let-7b-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7b-3p inhibitor
    hsa-let-7b-3p inhibitor
  • HY-RI00009

    MicroRNA Cancer
    hsa-let-7e-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7e-3p inhibitor
    hsa-let-7e-3p inhibitor
  • HY-RI00008

    MicroRNA Cancer
    hsa-let-7d-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7d-3p inhibitor
    hsa-let-7d-3p inhibitor
  • HY-RI00006

    MicroRNA Cancer
    hsa-let-7c-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7c-3p inhibitor
    hsa-let-7c-3p inhibitor
  • HY-RI00013

    MicroRNA Cancer
    hsa-let-7i-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7i-3p inhibitor
    hsa-let-7i-3p inhibitor
  • HY-RI00007

    MicroRNA Cancer
    hsa-let-7c-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7c-5p inhibitor
    hsa-let-7c-5p inhibitor
  • HY-RI00001

    MicroRNA Cancer
    hsa-let-7a-2-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-let-7a-2-3p inhibitor
    hsa-let-7a-2-3p inhibitor
  • HY-RI02558

    MicroRNA Cancer
    mmu-let-7a-2-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-let-7a-2-3p inhibitor
    mmu-let-7a-2-3p inhibitor
  • HY-RI02557

    MicroRNA Cancer
    mmu-let-7a-1-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-let-7a-1-3p inhibitor
    mmu-let-7a-1-3p inhibitor
  • HY-RI02559

    MicroRNA Cancer
    mmu-let-7f-2-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    mmu-let-7f-2-3p inhibitor
    mmu-let-7f-2-3p inhibitor

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: